A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With

Status Recruiting

Clinical Trial Summary

This investigation is a prospective, multicenter clinical investigation. It is anticipated that a total of 50 subjects will be enrolled at up to 5 sites. Enrollment is estimated to commence in Q4 of 2018. Neither subjects nor investigators are blinded to treatment and the clinical investigation includes a historical control which will be compared to the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System. Total duration of enrollment, 12 month follow-up and analysis is expected to take 29 months. The clinical investigation has been designed to follow the surgeon's standard of care for femur fractured subjects, in addition to a 12 month follow-up visit. The primary endpoint of this clinical investigation is to confirm efficacy/performance at 12 months, as measured by the Lower Extremity Measure (LEM). Confirmation of efficacy/performance at 12 months will be based on an equal or greater (non-inferior) LEM score result of the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System compared to the T2 Femur benchmark literature.

Clinical Trial Description

The objective of this clinical investigation is to demonstrate the safety and efficacy/performance of the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System. Efficacy/performance of the procedure will be measured by an equal or greater (non-inferior) Lower Extremity Measure (LEM) score result of the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System compared to the T2 Femur benchmark literature at 12 months. In addition, demonstration of bone consolidation in correct alignment will be measured by Investigator assessment by 12 months. Safety of the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System will be demonstrated through reporting of device related intra-operative and post-operative Adverse Events/incidents by 12 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04015154
Study type	Observational
Source	Stryker Trauma and Extremities
Contact	Monica Fleeman
Phone	251 465 5969
Email	monica.fleeman@stryker.com
Status	Recruiting
Phase
Start date	September 12, 2019
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05515718` - Effect of the Early Ultrasound-guided Femoral Nerve Block Performed by Emergency Physicians on Pre-operative Opioids Usage in Patients With Proximal Femoral Fractures	N/A
Recruiting	`NCT04494672` - A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System	N/A
Unknown status	`NCT01680120` - Dose Finding Study for Continuous Spinal Anaesthesia	Phase 4
Recruiting	`NCT04015128` - A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
Recruiting	`NCT05410587` - Fracture Monitor - Femur	N/A
Recruiting	`NCT05276674` - ZNN Bactiguard Retrograde Femoral Nails PMCF Study
Completed	`NCT02983344` - Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia	N/A
Terminated	`NCT00764959` - Retrospective Study of the Linear™ Hip	Phase 4
Completed	`NCT02069327` - The Role of Fat Emboli in the Trauma Inflammatory Response
Completed	`NCT03856502` - Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures	N/A
Recruiting	`NCT05559736` - Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures	N/A
Completed	`NCT03810092` - Analysis of the Relationship Between Early Postoperative Anemia and the Evolution of Autonomy at 6 Months in Patients 75 Years of Age and Older Operated on Following a Fracture of the Upper End of the Femur
Recruiting	`NCT05087667` - Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )	N/A
Recruiting	`NCT05523635` - Post Market Clinical Evaluation of Gamma 4
Recruiting	`NCT05274022` - Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture	N/A
Terminated	`NCT01300520` - The Development of a Surgical Localizing Aid Medical Device	N/A
Terminated	`NCT01141894` - Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture	N/A
Recruiting	`NCT05668182` - A Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects
Recruiting	`NCT05680987` - Retrograde Femoral Nail-Advanced Outcomes for Fixation of Distal Femur and Femoral Shaft Fractures	N/A
Not yet recruiting	`NCT04918680` - Prospective Post-market Study Examining the Effectiveness of the EcoFit®

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms